KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Non-Current Assets (2018 - 2026)

Takeda Pharmaceutical has reported Non-Current Assets over the past 9 years, most recently at $78.8 billion for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 2.55% year-over-year to $78.8 billion; the TTM value through Mar 2026 reached $78.8 billion, up 2.55%, while the annual FY2026 figure was $82.1 billion, 6.68% up from the prior year.
  • Non-Current Assets was $78.8 billion for Q1 2026 at Takeda Pharmaceutical, up from $76.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $91.1 billion in Q1 2022 and bottomed at $76.9 billion in Q1 2025.
  • The 5-year median for Non-Current Assets is $84.7 billion (2024), against an average of $83.8 billion.
  • Year-over-year, Non-Current Assets decreased 9.23% in 2025 and then rose 2.55% in 2026.
  • Over 5 years, Non-Current Assets stood at $91.1 billion in 2022, then dropped by 4.05% to $87.4 billion in 2023, then dropped by 3.1% to $84.7 billion in 2024, then fell by 9.23% to $76.9 billion in 2025, then rose by 2.55% to $78.8 billion in 2026.
  • The last three reported values for Non-Current Assets were $78.8 billion (Q1 2026), $76.9 billion (Q1 2025), and $84.7 billion (Q1 2024) per Business Quant data.